Scholarlink

Background <p>Incretin hormones, including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), along with glucagon, are regulators of appetite, energy balance, and fat metabolism. Despite their recognized functions, reference values for these hormones in children have not previously been established. This study aimed to establish age- and sex-specific reference percentiles and z-scores for GLP-1, GIP, and glucagon in children and to examine their associations with insulin resistance, lipid status, and metabolic syndrome.</p> Methods <p>Data were derived from the cohort of the study Childhood Health, Activity, and Motor Performance School Study Denmark (CHAMPS study DK) including 485 school children without metabolic syndrome.</p> Results <p>Age was positively associated with GLP-1 levels in both sexes, while GIP levels showed an inverse relationship with age in girls. Insulin sensitivity, as measured by Homeostatic Model Assessment 2 for Insulin Resistance (HOMA2-IR), was positively associated with GLP-1 z-scores in boys and glucagon z-scores in girls.</p> Conclusion <p>Age, sex and insulin sensitivity are important determinants of incretin and glucagon hormone levels in children. The reference percentiles and z-scores generated in this study provide a framework for future studies in pediatric metabolic health and disease.</p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p>This study provides age- and sex-specific reference values for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon in children and adolescents.</p> </ItemContent> <ItemContent> <p>This is the first publication presenting percentiles and z-scores for GLP-1 and GIP in children which is of value for future pediatric comparisons.</p> </ItemContent> <ItemContent> <p>Knowledge about normal physiology is of major importance for future research in the upcoming area of GLP-1, GIP and glucagon as potential biomarkers for metabolic disorders.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pediatric reference values for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon in children and adolescents

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月23日

查看全文
  • Trine Witzner Hessel Lawaetz,
  • Amalie Dalgas-Madsen,
  • Freja Cecilie Barrett Mørk,
  • Andreas Kryger Jensen,
  • Verena Hirschberg Jensen,
  • Flemming Pociot,
  • Malene Søborg Heidemann,
  • Anders Jørgen Shou,
  • Niels Wedderkopp,
  • Jesper Johannesen

摘要

Background

Incretin hormones, including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), along with glucagon, are regulators of appetite, energy balance, and fat metabolism. Despite their recognized functions, reference values for these hormones in children have not previously been established. This study aimed to establish age- and sex-specific reference percentiles and z-scores for GLP-1, GIP, and glucagon in children and to examine their associations with insulin resistance, lipid status, and metabolic syndrome.

Methods

Data were derived from the cohort of the study Childhood Health, Activity, and Motor Performance School Study Denmark (CHAMPS study DK) including 485 school children without metabolic syndrome.

Results

Age was positively associated with GLP-1 levels in both sexes, while GIP levels showed an inverse relationship with age in girls. Insulin sensitivity, as measured by Homeostatic Model Assessment 2 for Insulin Resistance (HOMA2-IR), was positively associated with GLP-1 z-scores in boys and glucagon z-scores in girls.

Conclusion

Age, sex and insulin sensitivity are important determinants of incretin and glucagon hormone levels in children. The reference percentiles and z-scores generated in this study provide a framework for future studies in pediatric metabolic health and disease.

Impact

This study provides age- and sex-specific reference values for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon in children and adolescents.

This is the first publication presenting percentiles and z-scores for GLP-1 and GIP in children which is of value for future pediatric comparisons.

Knowledge about normal physiology is of major importance for future research in the upcoming area of GLP-1, GIP and glucagon as potential biomarkers for metabolic disorders.